Related Experiment Video
Updated: Jul 10, 2026

08:20
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
Published on: May 21, 2019
Dimension reduction and mixed-effects model for microarray meta-analysis of cancer
Tianwei Yu1, Hui Ye, Zugen Chen
1Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. tyu8@emory.edu
Frontiers in Bioscience : a Journal and Virtual Library
|November 6, 2007
Summary
Combining microarray data enhances disease biomarker discovery by increasing statistical power. This study presents a method to merge datasets, revealing laboratory effects are more significant than platform differences.
Area of Science:
- Genomics
- Bioinformatics
- Biostatistics
Background:
- High-throughput microarray technologies accelerate disease biomarker discovery.
- Limited sample sizes in individual studies hinder full utilization of microarray data potential.
- Combining data from multiple studies enhances statistical power for detecting differentially expressed genes.
Purpose of the Study:
- To present a novel method for combining microarray datasets at the array probeset level.
- To investigate the influence of laboratory versus platform effects in multi-platform microarray data.
- To develop a visualization scheme for assessing agreement between merged array datasets.
Main Methods:
- Developed a method for combining microarray data at the array probeset level.
- Utilized datasets from Affymetrix Human Genome U133A and Human Genome U133 Plus 2.0 arrays.
- Applied a mixed-effects model for identifying differentially expressed genes in merged data.
Main Results:
- Laboratory effects were found to be more influential than platform effects.
- A visualization scheme was proposed to qualitatively assess agreement between datasets from different platforms.
- Differentially expressed genes were identified using a mixed-effects model on the merged data.
Conclusions:
- Merging microarray data from multiple studies is crucial for robust biomarker discovery.
- Laboratory conditions can significantly impact gene expression results, potentially more than the microarray platform itself.
- The proposed method and visualization aid in integrating diverse microarray datasets for enhanced biological insights.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

